RBC Capital Upgrades Incyte (INCY) to Outperform

RBC Capital upgraded Incyte (NASDAQ: INCY) from Sector Perform to Outperform with a price target of $120.00.

Analyst Brian Abrahams comments "With shares down considerably off their highs, and existing products/pipeline helping place a floor in shares, we believe reward/risk going into the epacadostat ph.III data has improved substantially and now see a buying opportunity ahead of the event."

For an analyst ratings summary and ratings history on Incyte click here. For more ratings news on Incyte click here.

Shares of Incyte closed at $94.71 Friday.

You May Also Be Interested In

• Diageo PLC. (DGE:LN) (DEO) PT Raised to GBP20.40 at TD Cowen
• Ardent Health Partners Inc (ARDT) PT Raised to $13 at RBC Capital
• Goldman Sachs Starts Standard Nuclear (STDN) at Buy